Tango Therapeutics TNGX Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

AmgenAMGN

1.4×+0.1×

Gilead SciencesGILD

1.3×0.0×

ExelixisEXEL

3.5×-0.1×

IDEAYA Biosciences, Inc.IDYA

10.7×-3.2×

Erasca, Inc.ERAS

9.5×-2.8×

FAQ

What is Tango Therapeutics's current ratio?

Tango Therapeutics (TNGX) reported current ratio of 27.4× in Q1 2026.

How has Tango Therapeutics's current ratio changed year-over-year?

Tango Therapeutics's current ratio increased by 337.2% year-over-year, from 6.3× to 27.4×.

What is the long-term trend for Tango Therapeutics's current ratio?

Over 5 years (2020 to 2025), Tango Therapeutics's current ratio has grown at a 28.1% compound annual growth rate (CAGR), from 4.7× to 16.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.